VSCAX
Price
$20.55
Change
-$1.97 (-8.75%)
Updated
Apr 3 closing price
Net Assets
6.34B
VSORX
Price
$40.96
Change
-$3.28 (-7.41%)
Updated
Apr 3 closing price
Net Assets
5.88B
Ad is loading...

VSCAX vs VSORX

Header iconVSCAX vs VSORX Comparison
Open Charts VSCAX vs VSORXBanner chart's image
Invesco Small Cap Value A
Price$20.55
Change-$1.97 (-8.75%)
VolumeN/A
Net Assets6.34B
Victory Sycamore Small Company Opp R6
Price$40.96
Change-$3.28 (-7.41%)
VolumeN/A
Net Assets5.88B
VSCAX vs VSORX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VSCAX vs. VSORX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCAX is a Hold and VSORX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 6.35B vs. VSORX (5.88B). VSORX pays higher dividends than VSCAX: VSORX (0.91) vs VSCAX (0.37). VSCAX was incepted earlier than VSORX: VSCAX (26 years) vs VSORX (9 years). VSCAX (1.12) is less costly to investors than VSORX (0.85). VSCAX is a more actively managed with annual turnover of: 40.00 vs. VSORX (37.00). VSORX has a lower initial minimum investment than VSCAX: VSORX (0) vs VSCAX (1000). VSCAX annual gain was more profitable for investors over the last year : -1.20 vs. VSORX (-8.83). VSCAX return over 5 years is better than : 216.20 vs. VSORX (54.22).
VSCAXVSORXVSCAX / VSORX
Total Expense Ratio1.120.85132%
Annual Report Gross Expense Ratio1.120.85132%
Fund Existence26 years9 years-
Gain YTD-4.211-6.01270%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.35B5.88B108%
Annual Yield % from dividends0.370.9140%
Returns for 1 year-1.20-8.8314%
Returns for 3 years13.84-9.29-149%
Returns for 5 years216.2054.22399%
Returns for 10 years9.77N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTTX12.85N/A
N/A
ICON Health and Information Tech Inv
BRXSX13.75N/A
N/A
MFS Blended Research Intl Eq R2
DGEYX20.42N/A
N/A
BNY Mellon Global Emerging Mkts - Y
GAOTX20.20N/A
N/A
JPMorgan Global Allocation R3
CBFFX36.62-0.68
-1.82%
American Funds Global Balanced 529F1